160 related articles for article (PubMed ID: 17602544)
21. In vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies.
Staelens L; Oltenfreiter R; Dumont F; Waterhouse RN; Vandenbulcke K; Blanckaert P; Dierckx RA; Slegers G
Nucl Med Biol; 2005 Feb; 32(2):193-200. PubMed ID: 15721765
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and preliminary evaluation of [123I]1-(4-cyanobenzyl)-4-[[(trans-iodopropen-2-yl)oxy]meth yl]piperidin e: a novel high affinity sigma receptor radioligand for SPECT.
Waterhouse RN; Mardon K; O'Brien JC
Nucl Med Biol; 1997 Jan; 24(1):45-51. PubMed ID: 9080474
[TBL] [Abstract][Full Text] [Related]
23. Syntheses and evaluation of a homologous series of aza-vesamicol as improved radioiodine-labeled probes for sigma-1 receptor imaging.
Ogawa K; Masuda R; Mishiro K; Wang M; Kozaka T; Shiba K; Kinuya S; Odani A
Bioorg Med Chem; 2019 May; 27(10):1990-1996. PubMed ID: 30975500
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Bioorg Med Chem; 2015 May; 23(9):2261-9. PubMed ID: 25800432
[TBL] [Abstract][Full Text] [Related]
25. Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.
McQuade P; Miao Y; Yoo J; Quinn TP; Welch MJ; Lewis JS
J Med Chem; 2005 Apr; 48(8):2985-92. PubMed ID: 15828837
[TBL] [Abstract][Full Text] [Related]
26. Melanoma uptake of (99m)Tc complexes containing the N-(2-diethylaminoethyl)benzamide structural element.
Eisenhut M; Mohammed A; Mier W; Schönsiegel F; Friebe M; Mahmood A; Jones AG; Haberkorn U
J Med Chem; 2002 Dec; 45(26):5802-5. PubMed ID: 12477363
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, radioiodination and in vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probes.
Maisonial A; Billaud EM; Besse S; Rbah-Vidal L; Papon J; Audin L; Bayle M; Galmier MJ; Tarrit S; Borel M; Askienazy S; Madelmont JC; Moins N; Auzeloux P; Miot-Noirault E; Chezal JM
Eur J Med Chem; 2013 May; 63():840-53. PubMed ID: 23603044
[TBL] [Abstract][Full Text] [Related]
28. Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.
Waterhouse RN; Mardon K; Giles KM; Collier TL; O'Brien JC
J Med Chem; 1997 May; 40(11):1657-67. PubMed ID: 9171875
[TBL] [Abstract][Full Text] [Related]
29. Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.
Labarre P; Papon J; Rose AH; Guerquin-Kern JL; Morandeau L; Wu TD; Moreau MF; Bayle M; Chezal JM; Croisy A; Madelmont JC; Turner H; Moins N
Nucl Med Biol; 2008 Oct; 35(7):783-91. PubMed ID: 18848663
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents.
Moreau MF; Michelot J; Papon J; Bayle M; Labarre P; Madelmont JC; Parry D; Boire JY; Moins N; Seguin H
Nucl Med Biol; 1995 Aug; 22(6):737-47. PubMed ID: 8535334
[TBL] [Abstract][Full Text] [Related]
31. Influence of trishomocubanes on sigma receptor binding of N-(1-benzyl-piperidin-4-yl)-4-[123I]iodobenzamide in vivo in the rat brain.
Liu X; Mattner F; Katsifis A; Christie M; Kassiou M
Med Chem; 2005 Jan; 1(1):31-8. PubMed ID: 16789883
[TBL] [Abstract][Full Text] [Related]
32. Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma.
Brandau W; Niehoff T; Pulawski P; Jonas M; Dutschka K; Sciuk J; Coenen HH; Schober O
J Nucl Med; 1996 Nov; 37(11):1865-71. PubMed ID: 8917194
[TBL] [Abstract][Full Text] [Related]
33. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of radioiodinated N-2-(4-piperidyl)ethyl benzamides.
Efange SM; Michelson RH; Knusel B; Hefti F; Boudreau RJ; Thomas JR; Tennison JR
Nucl Med Biol; 1993 May; 20(4):527-38. PubMed ID: 8504292
[TBL] [Abstract][Full Text] [Related]
35. In vivo evaluation of [18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a selective sigma-1 receptor radioligand for PET.
Waterhouse RN; Collier TL
Nucl Med Biol; 1997 Feb; 24(2):127-34. PubMed ID: 9089705
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of a (68)Ga-labeled N-(2-diethylaminoethyl)benzamide derivative as potential PET probe for malignant melanoma.
Kim HJ; Kim DY; Park JH; Yang SD; Hur MG; Min JJ; Yu KH
Bioorg Med Chem; 2012 Aug; 20(16):4915-20. PubMed ID: 22831797
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
John CS; Gulden ME; Vilner BJ; Bowen WD
Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
[TBL] [Abstract][Full Text] [Related]
38. Radioiodinated N-(alkylaminoalkyl)-substituted 4-methoxy-, 4-hydroxy-, and 4-aminobenzamides: biological investigations for the improvement of melanoma-imaging agents.
Mohammed A; Nicholl C; Titsch U; Eisenhut M
Nucl Med Biol; 1997 Jul; 24(5):373-80. PubMed ID: 9290070
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and characterization of a novel radioiodinated phenylacetamide and its homolog as theranostic agents for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Eur J Pharm Sci; 2016 Jan; 81():201-9. PubMed ID: 26517961
[TBL] [Abstract][Full Text] [Related]
40. Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.
Joyal JL; Barrett JA; Marquis JC; Chen J; Hillier SM; Maresca KP; Boyd M; Gage K; Nimmagadda S; Kronauge JF; Friebe M; Dinkelborg L; Stubbs JB; Stabin MG; Mairs R; Pomper MG; Babich JW
Cancer Res; 2010 May; 70(10):4045-53. PubMed ID: 20442292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
